ROX Medical is focused on the development of innovative devices for the treatment of chronic obstructive pulmonary disease.
ROX Medical is an early phase medical device company that is pioneering an innovative treatment for Chronic Obstructive Pulmonary Disease (COPD). Their therapy is intended to improve the delivery of oxygen to tissue to treat hypoxemia in COPD patients via the creation of a therapeutic fistula.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 6, 2016 | Series E | $40M | 1 | — | — | Detail |
Sep 6, 2012 | Series D | $6M | 1 | — | — | Detail |
Jun 13, 2008 | Series C | $32.99M | 1 | — | — | Detail |
Jul 25, 2006 | Series B | $10.10M | 1 | — | — | Detail |
Apr 21, 2004 | Series A | $3.59M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Series E |